logo
Loading...
Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma
Medicine and HealthNature Communications

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma

A. Nijhuis, A. Sikka, et al.

Discover how researchers Anke Nijhuis and colleagues have unleashed the potential of indisulam, a drug targeting RNA splicing factor RBM39, to combat high-risk neuroblastoma. Their groundbreaking study showcases complete tumor regression in xenograft models, reshaping our approach to pediatric cancer treatment.... show more
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny